Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities

Bioorg Med Chem. 2012 Aug 15;20(16):4901-14. doi: 10.1016/j.bmc.2012.06.048. Epub 2012 Jul 6.

Abstract

Phenserine is a potentially attractive drug for Alzheimer's disease. In order to further expand SAR study for inhibitions of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), the methyl group at the 3a-position of phenserine was replaced with an alkyl or alkenyl group, and its phenylcarbamoyl moiety was substituted at the o- or p-position. The synthetic methodology for these phenserine analogues includes the efficient cascade reactions for introduction of the 3a-substituent and assembly of the quaternary carbon center followed by reductive cyclization to the key pyrroloindoline structure. The bulkiness of the substituent at 3a-position of phenserine derivatives tends to reduce the inhibitory effect on AChE activity in the following order: methyl > ethyl > vinyl > propyl ≈ allyl > reverse-prenyl groups. Among the series synthesized, the 3a-ethyl derivative demonstrated the highest AChE selectivity. In construct, the 3a-reverse-prenyl derivative indicated modest BuChE selectivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholinesterase / metabolism*
  • Animals
  • Brain / enzymology
  • Butyrylcholinesterase / blood
  • Butyrylcholinesterase / metabolism*
  • Cholinesterase Inhibitors / chemical synthesis*
  • Cholinesterase Inhibitors / chemistry
  • Cholinesterase Inhibitors / pharmacology*
  • Dose-Response Relationship, Drug
  • Molecular Structure
  • Physostigmine / analogs & derivatives*
  • Physostigmine / chemistry
  • Physostigmine / pharmacology
  • Rats
  • Structure-Activity Relationship

Substances

  • Cholinesterase Inhibitors
  • Physostigmine
  • Acetylcholinesterase
  • Butyrylcholinesterase
  • phenserine